Medtronic Stock Price, News & Analysis (NYSE:MDT)

$86.40 1.08 (1.27 %)
(As of 01/17/2018 03:11 PM ET)
Previous Close$85.32
Today's Range$85.44 - $86.45
52-Week Range$73.59 - $89.72
Volume3.13 million shs
Average Volume5.53 million shs
Market Capitalization$115.48 billion
P/E Ratio23.74
Dividend Yield2.15%
Beta0.99

About Medtronic (NYSE:MDT)

Medtronic logoMedtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:MDT
CUSIP58505510
Phone353-1438-1700

Debt

Debt-to-Equity Ratio0.50%
Current Ratio2.40%
Quick Ratio2.05%

Price-To-Earnings

Trailing P/E Ratio23.7358516483516
Forward P/E Ratio18.11
P/E Growth2.35

Sales & Book Value

Annual Sales$29.71 billion
Price / Sales3.94
Cash Flow$6.88 per share
Price / Cash12.55
Book Value$36.83 per share
Price / Book2.35

Profitability

Trailing EPS$3.64
Net Income$4.03 billion
Net Margins16.93%
Return on Equity12.63%
Return on Assets6.51%

Miscellaneous

Employees91,000
Outstanding Shares1,353,500,000

Medtronic (NYSE:MDT) Frequently Asked Questions

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Friday, December 8th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.46 per share on Friday, January 19th. This represents a $1.84 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date of this dividend is Thursday, December 28th. View Medtronic's Dividend History.

How will Medtronic's stock buyback program work?

Medtronic announced that its board has initiated a stock repurchase plan on Thursday, October 5th 2017, which permits the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 49% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's board believes its shares are undervalued.

How were Medtronic's earnings last quarter?

Medtronic plc. (NYSE:MDT) issued its quarterly earnings results on Tuesday, November, 21st. The medical technology company reported $1.07 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.99 by $0.08. The medical technology company earned $7.05 billion during the quarter, compared to analyst estimates of $7.05 billion. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The company's quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.12 earnings per share. View Medtronic's Earnings History.

When will Medtronic make its next earnings announcement?

Medtronic is scheduled to release their next quarterly earnings announcement on Tuesday, February, 20th 2018. View Earnings Estimates for Medtronic.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its second quarter earnings guidance on Wednesday, November, 8th. The company provided earnings per share guidance of $1.04 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.94. The company issued revenue guidance of ~$7.1 billion, compared to the consensus revenue estimate of $6.87 billion.

Where is Medtronic's stock going? Where will Medtronic's stock price be in 2018?

22 equities research analysts have issued 1-year price targets for Medtronic's stock. Their forecasts range from $80.00 to $99.00. On average, they expect Medtronic's share price to reach $89.97 in the next year. View Analyst Ratings for Medtronic.

What are Wall Street analysts saying about Medtronic stock?

Here are some recent quotes from research analysts about Medtronic stock:

  • 1. According to Zacks Investment Research, "Medtronic exited the fiscal second quarter on a mixed note. While the company demonstrated improved segmental performances at CER, escalating costs and expenses continue to weigh on the bottom line. Unfavorable currency translation also acted as a dampener. On the bright side, all major business groups contributed to solid top-line growth at CER, which highlighted sustainability across groups and regions, in addition to displaying successful integration and achievement of synergy targets. We are also encouraged by the solid growth trend in the United States as well as healthy global acceptance of its advanced therapies. The recent receipt of FDA approval and commercial launch of Azure pacemakers with BlueSync technology buoy optimism. Apart from product innovation, the company is focusing on geographical diversification of its businesses. The stabilizing trend in the global Cardiac Rhythm & Heart Failure (CRHF) market is another upside." (11/23/2017)
  • 2. Needham & Company LLC analysts commented, "On 11/8/17, MDT preannounced F2Q18 revenue of $7.050B (up 3% organic Y/Y) vs. consensus of $6.897M. The impact from Hurricane Maria was revised down to ~$60M from ~$250M, which equates to ~1% in quarterly revenue growth and ~$0.03 in non-GAAP EPS. MDT did not update its FY18 revenue or EPS guidance in the press release but did reaffirm F2Q18 non-GAAP EPS growth of flat to slightly up, excluding the ~$0.03 headwind. MDT is scheduled to report full F2Q18 results on 11/21/17 and we intend to wait until then to update our model." (11/9/2017)
  • 3. BTIG Research analysts commented, "At last Friday's American College of Cardiology (ACC) meeting, two-year data on MDT's SURTAVI trial for intermediate-risk was presented. At the two-year mark, all cause death/stroke were similar for TAVR using MDT's valves (12.6%) vs. surgery (14%) though use of TAVR reduced 30-day strokes, kidney injury, afib, and hospital stay. While we were surprised TAVR was not superior to surgery as in other trials, it seems surgical results improved. Still, TAVR is at least as good with less invasiveness. While not the same trials, investors have tried to compare MDT's CoreValve to Edwards' (EW, Neutral) SAPIEN 3 based on available data. At 1 year, all-cause death and stroke were equivalent at 8.1% for CoreValve and 8.4% for SAPIEN 3. Overall, patient selection (EW's intermediate risk pool may have had more comorbidities) and device design (MDT mainly used its older valve) make it tough to directly compare both trials; but we believe the valves are essentially equivalent and either one should be chosen over surgery." (3/20/2017)
  • 4. Wedbush analysts commented, "Medtronic's broad product portfolio allows the company to navigate through temporary disruptions it might encounter in any given business unit, and today's FY3Q17 earnings results showcased management's ability to leverage its size and recover more quickly than we had expected from its disappointing FY2Q17 performance reported in November. With MDT's share price having mostly recovered from the post FY2Q17 selloff, we believe current valuation levels adequately reflect MDT's risk/reward profile and prefer to wait on the sidelines for a better entry point. ' FY3Q17 revenue of $7,283 million (+6% yr/yr, ex-FX) beat consensus revenue estimate of $7,220 million. Revenue from all four segments exceeded consensus, with the biggest contribution from Minimally Invasive Therapies Group (MTIG) and Diabetes' Our $85 PT is based on applying a 16x P/E multiple on our MDT forward EPS estimate, 12 months hence." (2/22/2017)

Are investors shorting Medtronic?

Medtronic saw a decline in short interest in the month of November. As of November 30th, there was short interest totalling 8,678,569 shares, a decline of 29.9% from the November 15th total of 12,387,732 shares. Based on an average daily volume of 6,051,050 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.6% of the shares of the company are short sold.

Who are some of Medtronic's key competitors?

Who owns Medtronic stock?

Medtronic's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Vontobel Asset Management Inc. (0.28%), Factory Mutual Insurance Co. (0.08%), Gateway Investment Advisers LLC (0.08%), Hexavest Inc. (0.04%), Nisa Investment Advisors LLC (0.04%) and Davis R M Inc. (0.03%). Company insiders that own Medtronic stock include Bryan C Hanson, Carol A Surface, Gary Lee Ellis, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, James T Lenehan, Kendall J Powell, Omar Ishrak, Richard H Anderson, Richard Kuntz, Robert C Pozen and Shirley A Jackson. View Institutional Ownership Trends for Medtronic.

Who sold Medtronic stock? Who is selling Medtronic stock?

Medtronic's stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Exxonmobil Investment Management Inc. TX, Pennsylvania Trust Co, Davis R M Inc., Hudson Valley Investment Advisors Inc. ADV, Nisa Investment Advisors LLC, F&V Capital Management LLC and Louisiana State Employees Retirement System. Company insiders that have sold Medtronic company stock in the last year include Bryan C Hanson, Hoedt Rob Ten, Hooman Hakami, Omar Ishrak and Richard Kuntz. View Insider Buying and Selling for Medtronic.

Who bought Medtronic stock? Who is buying Medtronic stock?

Medtronic's stock was acquired by a variety of institutional investors in the last quarter, including Vontobel Asset Management Inc., Gateway Investment Advisers LLC, Factory Mutual Insurance Co., Sawyer & Company Inc, Union Bankshares Corp, Access Financial Services Inc., 440 Investment Group LLC and Whalerock Point Partners LLC. Company insiders that have bought Medtronic stock in the last two years include James T Lenehan, Richard H Anderson and Robert C Pozen. View Insider Buying and Selling for Medtronic.

How do I buy Medtronic stock?

Shares of Medtronic can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medtronic's stock price today?

One share of Medtronic stock can currently be purchased for approximately $85.32.

How big of a company is Medtronic?

Medtronic has a market capitalization of $115.48 billion and generates $29.71 billion in revenue each year. The medical technology company earns $4.03 billion in net income (profit) each year or $3.64 on an earnings per share basis. Medtronic employs 91,000 workers across the globe.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]


MarketBeat Community Rating for Medtronic (MDT)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  873 (Vote Outperform)
Underperform Votes:  560 (Vote Underperform)
Total Votes:  1,433
MarketBeat's community ratings are surveys of what our community members think about Medtronic and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medtronic (NYSE:MDT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.642.572.552.61
Ratings Breakdown: 0 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
10 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $89.97$88.75$88.00$89.26
Price Target Upside: 9.44% upside9.20% upside14.39% upside3.72% upside

Medtronic (NYSE:MDT) Consensus Price Target History

Price Target History for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/3/2018Evercore ISIInitiated CoverageOutperform -> Outperform$92.50HighView Rating Details
1/2/2018Bank of AmericaUpgradeNeutral -> BuyHighView Rating Details
12/21/2017OppenheimerReiterated RatingBuyLowView Rating Details
12/12/2017ArgusUpgradeHold -> Buy$81.27 -> $95.00LowView Rating Details
12/12/2017BMO Capital MarketsBoost Price TargetOutperform$94.00LowView Rating Details
11/23/2017Jefferies GroupReiterated RatingBuy$99.00N/AView Rating Details
11/22/2017Northland SecuritiesReiterated RatingHold$80.00N/AView Rating Details
11/22/2017Stifel NicolausBoost Price TargetHold$83.00 -> $85.00N/AView Rating Details
11/19/2017SunTrust BanksSet Price TargetBuy$92.00N/AView Rating Details
11/9/2017Needham & Company LLCReiterated RatingBuy$94.00N/AView Rating Details
11/3/2017CowenReiterated RatingBuy$95.00N/AView Rating Details
10/9/2017Leerink SwannReiterated RatingMarket Perform$88.00 -> $85.00N/AView Rating Details
10/9/2017Royal Bank of CanadaLower Price TargetOutperform -> Outperform$90.00 -> $85.00N/AView Rating Details
10/9/2017Wells Fargo & CoDowngradeOutperform -> Market Perform$93.00 -> $83.00N/AView Rating Details
8/23/2017BarclaysLower Price TargetOverweight$94.00 -> $92.00LowView Rating Details
7/31/2017Deutsche BankSet Price TargetBuy$96.00LowView Rating Details
7/6/2017William BlairReiterated RatingOutperformMediumView Rating Details
5/30/2017Morgan StanleyBoost Price TargetEqual Weight$84.00 -> $86.00LowView Rating Details
5/26/2017CIBCReiterated RatingBuyLowView Rating Details
5/16/2017Goldman Sachs GroupInitiated CoverageNeutral -> Neutral$87.00LowView Rating Details
3/20/2017BTIG ResearchReiterated RatingNeutralLowView Rating Details
2/22/2017WedbushReiterated RatingNeutral$85.00N/AView Rating Details
1/3/2017JPMorgan Chase & Co.DowngradeOverweight -> Neutral$84.00 -> $79.00N/AView Rating Details
8/25/2016Credit Suisse GroupReiterated RatingOutperform$92.00N/AView Rating Details
8/23/2016CitigroupInitiated CoverageBuy$63.98 -> $102.00N/AView Rating Details
6/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$93.00 -> $94.00N/AView Rating Details
6/8/2016GuggenheimInitiated CoverageNeutralN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$86.00N/AView Rating Details
(Data available from 1/17/2016 forward)

Earnings

Medtronic (NYSE:MDT) Earnings History and Estimates Chart

Earnings by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE MDT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/20/2018$1.17N/AView Earnings Details
11/21/2017Q2 18$0.99$1.07$7.05 billion$7.05 billionViewN/AView Earnings Details
8/22/20177/31/2017$1.08$1.12$7.44 billion$7.39 billionViewN/AView Earnings Details
5/25/2017Q4 17$1.31$1.33$7.86 billion$7.92 billionViewN/AView Earnings Details
2/21/20171/31/2017$1.11$1.12$7.22 billion$7.28 billionViewListenView Earnings Details
11/22/2016Q217$1.11$1.12$7.46 billion$7.35 billionViewListenView Earnings Details
8/25/2016Q117$1.01$1.03$7.17 billion$7.20 billionViewListenView Earnings Details
5/31/2016Q416$1.26$1.27$7.49 billion$7.57 billionViewListenView Earnings Details
3/1/2016Q316$1.06$1.06$6.99 billion$6.93 billionViewListenView Earnings Details
12/3/2015Q216$1.00$1.03$7.08 billion$7.06 billionViewListenView Earnings Details
9/3/2015Q116$1.01$1.02$7.03 billion$7.27 billionViewListenView Earnings Details
6/2/2015Q415$1.11$1.16$7.18 billion$7.30 billionViewListenView Earnings Details
2/17/2015Q3$0.97$1.01$4.25 million$4.32 millionViewListenView Earnings Details
11/18/2014Q2$0.96$0.96$4.37 million$4.40 millionViewListenView Earnings Details
8/19/2014Q115$0.92$0.93$4.25 billion$4.27 billionViewListenView Earnings Details
5/20/2014Q414$1.12$1.12$4.58 billion$4.60 billionViewListenView Earnings Details
2/18/2014Q314$0.91$0.91$4.15 billion$4.20 billionViewListenView Earnings Details
11/19/2013Q214$0.90$0.91$4.18 billion$4.20 billionViewListenView Earnings Details
8/20/2013Q1 2014$0.88$0.88$4.11 billion$4.10 billionViewListenView Earnings Details
5/21/2013Q4 2013$1.03$1.10$4.39 billion$4.50 billionViewListenView Earnings Details
2/19/2013Q3 2013$0.91$0.93$4.03 billion$4.03 billionViewListenView Earnings Details
11/20/20120.88$0.88$4.10 billionViewN/AView Earnings Details
8/21/2012$0.85$0.85ViewN/AView Earnings Details
5/22/2012$0.98$0.99ViewN/AView Earnings Details
2/21/2012$0.84$0.88ViewN/AView Earnings Details
11/22/2011$0.82$0.84ViewN/AView Earnings Details
8/23/2011$0.79$0.79ViewN/AView Earnings Details
5/24/2011$0.93$0.90ViewN/AView Earnings Details
2/22/2011$0.84$0.86ViewN/AView Earnings Details
11/23/2010Q2 2011$0.81$0.82ViewN/AView Earnings Details
8/24/2010Q1 2011$0.82$0.80ViewN/AView Earnings Details
5/25/2010Q4 2010$0.88$0.89ViewN/AView Earnings Details
2/23/2010Q3 2010$0.76$0.77ViewN/AView Earnings Details
11/24/2009Q2 2010$0.74$0.77ViewN/AView Earnings Details
8/25/2009Q1 2010$0.78$0.79ViewN/AView Earnings Details
5/19/2009Q4 2009$0.82$0.82ViewN/AView Earnings Details
2/17/2009Q3 2009$0.71$0.71ViewN/AView Earnings Details
11/18/2008Q2 2009$0.71$0.67ViewN/AView Earnings Details
8/19/2008Q1 2009$0.69$0.72ViewN/AView Earnings Details
5/20/2008Q4 2008$0.73$0.78ViewN/AView Earnings Details
2/19/2008Q3 2008$0.61$0.63ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Medtronic (NYSE:MDT) Earnings Estimates

2018 EPS Consensus Estimate: $4.74
2019 EPS Consensus Estimate: $5.22
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20186$1.07$1.15$1.10
Q2 20187$0.89$1.20$1.03
Q3 20187$1.15$1.24$1.19
Q4 20187$1.40$1.46$1.42
Q1 20194$1.16$1.24$1.21
Q2 20194$1.17$1.26$1.21
Q3 20194$1.27$1.34$1.30
Q4 20194$1.43$1.57$1.51
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Medtronic (NYSE:MDT) Dividend Information

Next Dividend:1/19/2018
Annual Dividend:$1.84
Dividend Yield:2.13%
Dividend Growth:15.00% (3 Year Average)
Payout Ratio:50.55% (Trailing 12 Months of Earnings)
38.57% (Based on This Year's Estimates)
35.66% (Based on Next Year's Estimates)
Track Record:40 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/8/2017Quarterly$0.4612/28/201712/29/20171/19/2018
8/28/2017Quarterly$0.462.31%9/28/20179/29/201710/20/2017
6/23/2017Quarterly$0.462.07%7/5/20177/7/20177/26/2017
3/10/2017Quarterly$0.432.08%3/22/20173/24/20174/13/2017
12/9/2016quarterly$0.432.33%12/21/201612/23/20161/13/2017
8/22/2016Quarterly$0.431.98%9/27/20169/29/201610/21/2016
6/24/2016quarterly$0.431.85%7/6/20167/8/20167/27/2016
2/22/2016quarterly$0.381.98%3/22/20163/24/20164/15/2016
12/11/2015quarterly$0.381.96%12/22/201512/24/20151/15/2016
8/21/2015quarterly$0.382.18%9/23/20159/25/201510/16/2015
6/19/2015quarterly$0.381.97%6/25/20156/29/20157/17/2015
2/20/2015quarterly$0.311.55%3/26/20153/30/20154/17/2015
12/4/2014$0.3112/30/20141/2/20151/16/2015
12/5/2014quarterly$0.311.63%12/30/20141/2/20151/6/2015
8/21/2014quarterly$0.311.92%10/1/201410/3/201410/24/2014
6/16/2014quarterly$0.311.98%7/1/20147/3/20147/25/2014
2/14/2014quarterly$0.281.97%4/2/20144/4/20144/25/2014
12/5/2013quarterly$0.281.93%12/31/20131/3/20141/24/2014
8/22/2013quarterly$0.282.12%10/2/201310/4/201310/25/2013
6/21/2013quarterly$0.282.13%7/2/20137/5/20137/26/2013
2/15/2013quarterly$0.262.21%4/3/20134/5/20134/26/2013
12/9/2012quarterly$0.262.44%12/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Medtronic (NYSE MDT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.31%
Institutional Ownership Percentage: 81.75%
Insider Trades by Quarter for Medtronic (NYSE:MDT)
Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Medtronic (NYSE MDT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/9/2018Richard KuntzVPSell78,526$86.21$6,769,726.46149,761View SEC Filing  
1/5/2018Hooman HakamiEVPSell26,158$85.00$2,223,430.00View SEC Filing  
12/15/2017Bryan C HansonEVPSell16,000$82.82$1,325,120.0088,818View SEC Filing  
11/16/2017Bryan C. HansonEVPSell16,000$79.02$1,264,320.00View SEC Filing  
10/16/2017Bryan C HansonEVPSell16,000$78.03$1,248,480.00View SEC Filing  
9/15/2017Omar IshrakCEOSell140,407$81.63$11,461,423.41668,503View SEC Filing  
7/17/2017Bryan C. HansonEVPSell12,000$88.57$1,062,840.00View SEC Filing  
6/21/2017Richard H AndersonDirectorBuy5,600$88.90$497,840.0071,910View SEC Filing  
3/20/2017Hoedt Rob TenEVPSell50,757$81.58$4,140,756.0659,392View SEC Filing  
3/15/2017Omar IshrakCEOSell95,000$82.82$7,867,900.00645,616View SEC Filing  
3/2/2017Hooman HakamiEVPSell52,316$82.33$4,307,176.2873,800View SEC Filing  
12/13/2016Robert C. PozenDirectorBuy13,660$73.21$1,000,048.60View SEC Filing  
11/23/2016James T. LenehanDirectorBuy2,000$73.27$146,540.00View SEC Filing  
9/27/2016Richard KuntzVPSell17,141$86.70$1,486,124.70149,425View SEC Filing  
9/26/2016Richard KuntzVPSell25,199$86.67$2,183,997.33149,425View SEC Filing  
9/15/2016Kendall J. PowellDirectorSell7,907$85.45$675,653.15View SEC Filing  
9/15/2016Omar IshrakCEOSell61,925$84.93$5,259,290.25565,916View SEC Filing  
8/29/2016Bryan C HansonEVPSell15,000$87.00$1,305,000.00168,192View SEC Filing  
7/26/2016Bryan C HansonEVPSell15,000$87.00$1,305,000.00108,717View SEC Filing  
7/15/2016Geoffrey MarthaEVPSell3,766$88.26$332,387.16View SEC Filing  
7/13/2016Gary Lee EllisEVPSell35,495$88.64$3,146,276.80View SEC Filing  
7/13/2016Shirley A JacksonDirectorSell2,104$88.64$186,498.5634,503View SEC Filing  
7/6/2016Carol A. SurfaceSVPSell9,787$87.08$852,251.96View SEC Filing  
7/5/2016Bryan C. HansonEVPSell15,272$87.11$1,330,343.92View SEC Filing  
6/3/2016Richard KuntzVPSell49,905$82.60$4,122,153.00127,647View SEC Filing  
4/1/2016Richard KuntzVPSell4,000$75.22$300,880.00104,358View SEC Filing  
3/18/2016Shirley A JacksonDirectorSell1,238$75.60$93,592.8029,812View SEC Filing  
3/17/2016Omar IshrakCEOSell23,799$76.15$1,812,293.85601,838View SEC Filing  
3/4/2016Bryan C HansonEVPSell5,000$75.00$375,000.0096,806View SEC Filing  
2/5/2016Bryan C. HansonEVPSell5,000$76.14$380,700.00View SEC Filing  
1/8/2016Bryan C HansonEVPSell5,000$75.00$375,000.00106,514View SEC Filing  
12/4/2015Richard KuntzVPSell13,715$78.06$1,070,592.90108,086View SEC Filing  
9/15/2015Omar IshrakCEOSell20,000$69.43$1,388,600.00526,824View SEC Filing  
7/14/2015Carol A SurfaceSVPSell13,722$75.83$1,040,539.26View SEC Filing  
4/6/2015Richard KuntzVPSell31,768$77.39$2,458,525.52View SEC Filing  
3/25/2015Gary Lee EllisCFOSell43,183$77.81$3,360,069.23View SEC Filing  
3/13/2015Omar IshrakCEOSell20,000$76.24$1,524,800.00View SEC Filing  
2/19/2015Christopher J OconnellEVPSell50,361$78.22$3,939,237.42View SEC Filing  
12/19/2014Richard KuntzVPSell12,855$74.54$958,211.70View SEC Filing  
12/2/2014Shirley A JacksonDirectorSell1,102$74.43$82,021.86View SEC Filing  
11/28/2014Christopher J OconnellEVPSell42,921$73.95$3,174,007.95View SEC Filing  
10/6/2014Christopher J OconnellEVPSell15,388$64.98$999,912.24View SEC Filing  
8/26/2014Christopher J OconnellEVPSell28,000$63.57$1,779,960.00View SEC Filing  
8/26/2014Shirley A JacksonDirectorSell2,769$63.66$176,274.54View SEC Filing  
4/17/2014Catherine SzymanVPSell29,420$58.79$1,729,601.8021,602View SEC Filing  
4/9/2014Richard KuntzVPSell2,512$60.98$153,181.76104,736View SEC Filing  
4/1/2014Gary Lee EllisCFOSell4,246$61.48$261,044.08174,955View SEC Filing  
3/28/2014Christopher OconnellEVPSell1,982$60.39$119,692.98120,652View SEC Filing  
3/20/2014Catherine SzymanVPSell14,979$59.57$892,299.0321,542View SEC Filing  
3/14/2014Omar IshrakCEOSell10,000$59.12$591,200.00607,192View SEC Filing  
3/10/2014Neil AyotteVPSell1,845$59.64$110,035.8010,782View SEC Filing  
12/4/2013Neil AyotteVPSell1,729$57.14$98,795.0610,850View SEC Filing  
9/13/2013Omar IshrakCEOSell10,000$53.58$535,800.00611,713View SEC Filing  
8/26/2013Catherine SzymanVPSell56,998$52.60$2,998,094.8021,217View SEC Filing  
8/22/2013H James DallasVPSell32,332$53.19$1,719,739.0859,141View SEC Filing  
8/21/2013H James DallasVPSell36,256$52.82$1,915,041.9291,473View SEC Filing  
8/21/2013Shirley JacksonDirectorSell8,033$52.84$424,463.7224,943View SEC Filing  
7/11/2013Christopher J OconnellEVPSell30,429$52.92$1,610,302.68View SEC Filing  
7/11/2013Gary Lee EllisCFOSell32,602$53.62$1,748,119.24View SEC Filing  
7/11/2013H James DallasVPSell69,889$53.72$3,754,437.08View SEC Filing  
7/1/2013H James DallasVPSell20,579$52.10$1,072,165.90View SEC Filing  
6/26/2013D Cameron FindlayVPSell75,042$52.20$3,917,192.40View SEC Filing  
6/19/2013H James DallasVPSell94,117$52.74$4,963,730.58View SEC Filing  
5/22/2013Richard H AndersonDirectorBuy4,800$52.32$251,136.00View SEC Filing  
5/10/2013Jack W SchulerDirectorSell34,230$48.24$1,651,255.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Medtronic (NYSE MDT) News Headlines

Source:
DateHeadline
Why Medtronic plc’s (NYSE:MDT) ROE Of 9.83% Does Not Tell The Whole StoryWhy Medtronic plc’s (NYSE:MDT) ROE Of 9.83% Does Not Tell The Whole Story
finance.yahoo.com - January 17 at 9:48 AM
Medtronic (MDT) Wins FDA Nod for New Clinician ProgrammerMedtronic (MDT) Wins FDA Nod for New Clinician Programmer
finance.yahoo.com - January 17 at 9:48 AM
Politics in China weighs heavily on businessPolitics in China weighs heavily on business
finance.yahoo.com - January 17 at 9:48 AM
Medtronic Receives FDA Clearance for Riptide(TM) Aspiration SystemMedtronic Receives FDA Clearance for Riptide(TM) Aspiration System
finance.yahoo.com - January 16 at 4:57 PM
Medtronic's ITB Therapy Superior to CMM for PSS ReductionMedtronic's ITB Therapy Superior to CMM for PSS Reduction
finance.yahoo.com - January 16 at 9:55 AM
AP Top Extended Financial Headlines at 8:23 a.m. ESTAP Top Extended Financial Headlines at 8:23 a.m. EST
finance.yahoo.com - January 15 at 9:48 AM
China rebukes Zara, Delta for calling Taiwan 'country'China rebukes Zara, Delta for calling Taiwan 'country'
finance.yahoo.com - January 12 at 9:57 AM
China rebukes Zara, Delta for calling Taiwan countryChina rebukes Zara, Delta for calling Taiwan 'country'
marketbeat.com - January 12 at 2:54 AM
New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke SpasticityNew Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity
finance.yahoo.com - January 11 at 10:13 AM
Insider Selling: Medtronic plc. (MDT) VP Sells 78,526 Shares of StockInsider Selling: Medtronic plc. (MDT) VP Sells 78,526 Shares of Stock
www.americanbankingnews.com - January 10 at 6:46 PM
Stryker Stock: Wall Street Recommendations and Target PriceStryker Stock: Wall Street Recommendations and Target Price
finance.yahoo.com - January 10 at 4:57 PM
FDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe SpasticityFDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe Spasticity
finance.yahoo.com - January 10 at 10:00 AM
Medtronic announces restructuring to trim costs by billionsMedtronic announces restructuring to trim costs by billions
finance.yahoo.com - January 9 at 5:01 PM
Discussing Baxter International’s Recent Stock Price HighsDiscussing Baxter International’s Recent Stock Price Highs
finance.yahoo.com - January 9 at 5:01 PM
Medtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation ProgrammingMedtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation Programming
finance.yahoo.com - January 9 at 9:52 AM
Favorable Regulatory Trends & Recent FDA Clearance Indicate Big Returns For BTCY Shareholders in 2018Favorable Regulatory Trends & Recent FDA Clearance Indicate Big Returns For BTCY Shareholders in 2018
finance.yahoo.com - January 9 at 9:52 AM
Medtronic PLC Stock Is a Long Term Investment LockMedtronic PLC Stock Is a Long Term Investment Lock
investorplace.com - January 9 at 8:05 AM
Medtronic plc. (MDT) EVP Sells $2,223,430.00 in StockMedtronic plc. (MDT) EVP Sells $2,223,430.00 in Stock
www.americanbankingnews.com - January 8 at 6:50 PM
Medtronic unveils restructuring planMedtronic unveils restructuring plan
finance.yahoo.com - January 8 at 5:04 PM
Medtronic plc. (MDT) Receives Consensus Rating of "Buy" from BrokeragesMedtronic plc. (MDT) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 5 at 5:50 PM
Medtronic plc. (MDT) Expected to Announce Quarterly Sales of $7.20 BillionMedtronic plc. (MDT) Expected to Announce Quarterly Sales of $7.20 Billion
www.americanbankingnews.com - January 5 at 4:30 PM
 Brokerages Expect Medtronic plc. (MDT) Will Announce Earnings of $1.17 Per Share Brokerages Expect Medtronic plc. (MDT) Will Announce Earnings of $1.17 Per Share
www.americanbankingnews.com - January 3 at 1:36 AM
Implied RYH Analyst Target Price: $198Implied RYH Analyst Target Price: $198
www.nasdaq.com - January 2 at 9:49 AM
Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare ConferenceMedtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
finance.yahoo.com - December 29 at 4:54 PM
Medtronic Plc : MDT-US: Dividend Analysis : December 29th, 2017 (record date) : By the numbers : December 29, 2017Medtronic Plc : MDT-US: Dividend Analysis : December 29th, 2017 (record date) : By the numbers : December 29, 2017
finance.yahoo.com - December 29 at 10:23 AM
Medtronic Stock Positioned for an Uptrend after a Bearish RunMedtronic Stock Positioned for an Uptrend after a Bearish Run
finance.yahoo.com - December 28 at 3:39 PM
Recent Recommendation Revisions on MedtronicRecent Recommendation Revisions on Medtronic
finance.yahoo.com - December 28 at 10:35 AM
Why Argus Upgraded MDT Stock from ‘Hold’ to ‘Buy’ on December 12Why Argus Upgraded MDT Stock from ‘Hold’ to ‘Buy’ on December 12
finance.yahoo.com - December 28 at 10:35 AM
Discussing the Recent Management Changes at MedtronicDiscussing the Recent Management Changes at Medtronic
finance.yahoo.com - December 27 at 5:51 PM
Medtronic Strengthens Its Endoscopy Business through Crospon AcquisitionMedtronic Strengthens Its Endoscopy Business through Crospon Acquisition
finance.yahoo.com - December 27 at 5:51 PM
Medtronic’s New Telehealth Solution for VeteransMedtronic’s New Telehealth Solution for Veterans
finance.yahoo.com - December 27 at 5:51 PM
ETFs with exposure to Medtronic Plc : December 25, 2017ETFs with exposure to Medtronic Plc : December 25, 2017
finance.yahoo.com - December 25 at 6:40 PM
Medtronic plc. (MDT) Declares Quarterly Dividend of $0.46Medtronic plc. (MDT) Declares Quarterly Dividend of $0.46
www.americanbankingnews.com - December 23 at 8:09 PM
Medtronic (MDT) Down 1.5% Since Earnings Report: Can It Rebound?Medtronic (MDT) Down 1.5% Since Earnings Report: Can It Rebound?
finance.yahoo.com - December 22 at 10:03 AM
Medtronics (MDT) "Buy" Rating Reaffirmed at OppenheimerMedtronic's (MDT) "Buy" Rating Reaffirmed at Oppenheimer
www.americanbankingnews.com - December 21 at 1:00 PM
Cramer: Zimmer Biomet becoming a buy thanks to new CEOCramer: Zimmer Biomet becoming a buy thanks to new CEO
finance.yahoo.com - December 21 at 9:55 AM
Cramer says Zimmer Biomet is becoming a buy thanks to its...Cramer says Zimmer Biomet is becoming a buy thanks to its...
finance.yahoo.com - December 21 at 9:55 AM
We Like Zimmers Pick for CEOWe Like Zimmer's Pick for CEO
finance.yahoo.com - December 20 at 9:58 AM
$7.20 Billion in Sales Expected for Medtronic plc. (MDT) This Quarter$7.20 Billion in Sales Expected for Medtronic plc. (MDT) This Quarter
www.americanbankingnews.com - December 19 at 12:16 PM
US stocks start little changed after climbing to new highsUS stocks start little changed after climbing to new highs
marketbeat.com - December 19 at 10:15 AM
Bob White Named Executive Vice President and President of Medtronics Minimally Invasive TherapiesBob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies
www.nasdaq.com - December 19 at 9:56 AM
Medtronic PLC (MDT) QuoteMedtronic PLC (MDT) Quote
www.reuters.com - December 19 at 9:56 AM
Bob White Named Executive Vice President and President of Medtronics Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronics Asia Pacific RegionBob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
finance.yahoo.com - December 19 at 9:56 AM
How Safe Is Medtronics Dividend?How Safe Is Medtronic's Dividend?
www.fool.com - December 19 at 8:25 AM
Medtronic plc. (MDT) EVP Sells $1,325,120.00 in StockMedtronic plc. (MDT) EVP Sells $1,325,120.00 in Stock
www.americanbankingnews.com - December 18 at 8:36 PM
Interesting MDT Put And Call Options For August 2018Interesting MDT Put And Call Options For August 2018
www.nasdaq.com - December 18 at 4:57 PM
Medtronic PLC (MDT) Short Interest Down 29.9% in NovemberMedtronic PLC (MDT) Short Interest Down 29.9% in November
www.americanbankingnews.com - December 18 at 5:12 AM
BMO Capital Markets Boosts Medtronic (MDT) Price Target to $94.00BMO Capital Markets Boosts Medtronic (MDT) Price Target to $94.00
www.americanbankingnews.com - December 17 at 9:26 PM
Medtronic PLC (MDT) Expected to Announce Earnings of $1.17 Per ShareMedtronic PLC (MDT) Expected to Announce Earnings of $1.17 Per Share
www.americanbankingnews.com - December 17 at 7:46 AM
Medtronic pays $2.4M to Mass. to settle false marketing allegationsMedtronic pays $2.4M to Mass. to settle false marketing allegations
www.bizjournals.com - December 13 at 5:08 PM

SEC Filings

Medtronic (NYSE:MDT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Medtronic (NYSE:MDT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medtronic (NYSE MDT) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.